8079912|t|Tacrine therapy for the dementia of Alzheimer's disease.
8079912|a|Tacrine, a centrally acting cholinesterase inhibitor, may improve cognitive and functional status in patients with mild to moderate Alzheimer's disease. In recent controlled trials, patients have shown improvement in cognitive assessment scores, but the clinical significance of such benefits remains unclear. Appropriate diagnostic evaluation is necessary to prevent inappropriate treatment in patients with non-Alzheimer's dementia. Hepatotoxicity and gastrointestinal symptoms are common adverse effects of tacrine, and frequent monitoring of liver function is required.
8079912	0	7	Tacrine	Chemical	MESH:D013619
8079912	24	32	dementia	Disease	MESH:D003704
8079912	36	55	Alzheimer's disease	Disease	MESH:D000544
8079912	57	64	Tacrine	Chemical	MESH:D013619
8079912	85	99	cholinesterase	Gene	590
8079912	158	166	patients	Species	9606
8079912	189	208	Alzheimer's disease	Disease	MESH:D000544
8079912	239	247	patients	Species	9606
8079912	452	460	patients	Species	9606
8079912	470	490	Alzheimer's dementia	Disease	MESH:D000544
8079912	492	506	Hepatotoxicity	Disease	
8079912	511	536	gastrointestinal symptoms	Disease	MESH:D012817
8079912	567	574	tacrine	Chemical	MESH:D013619
8079912	Positive_Correlation	MESH:D013619	MESH:D012817
8079912	Negative_Correlation	MESH:D013619	590
8079912	Negative_Correlation	MESH:D013619	MESH:D003704
8079912	Negative_Correlation	MESH:D013619	MESH:D000544

